Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Aitbaev

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Sovetskoe Zdravookhranenie Kirgizii|November 1, 1973
[Blood phospholipids in patients with Down's disease]K A Aitbaev
Klinicheskaia Meditsina|October 11, 2018
[INTESTINAL MICROBIOTA: ITS ROLE IN PATHOGENESIS OF ARTERIAL HYPERTENSION]K A Aitbaev, I E Murkamilov
Klinicheskaia Meditsina|October 6, 2018
[Peculiarities of progression of chronic glomerulonephritis associated with anemia]I T Murkamilov, K A Aitbaev, R Kaliev
Terapevticheskii Arkhiv|December 6, 2022
[Circulating microRNAs as potential biomarkers of chronic kidney disease]K A Aitbaev, I T Murkamilov, V V Fomin
Kardiologiia|March 12, 2019
K A Aitbaev, I T Murkamilov, V V Fomin
Terapevticheskii Arkhiv|December 30, 2023
[Prevalence, age and gender features of chronic kidney disease in patients with diabetes mellitus]I T Murkamilov, K A Aitbaev, V V Fomin
Terapevticheskii Arkhiv|July 27, 2017
[Gender features of cardiovascular events in patients with chronic glomerulonephritis at the pre-dialysis stage of the disease]I T Murkamilov, K A Aitbaev, V V Fomin
Terapevticheskii Arkhiv|September 16, 2017
[Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation]K A Aitbaev, I T Murkamilov, V V Fomin
Advances in Gerontology = Uspekhi Gerontologii|June 23, 2019
[Molecular mechanisms of aging: the role of oxidative stress and epigenetic modifications.]K A Aitbaev, I T Murkamilov, V V Fomin
Terapevticheskii Arkhiv|February 1, 2019
Inhibition of HIF-prolyl 4-hydroxylases as a promising approach to the therapy of cardiometabolic diseasesK A Aitbaev, I Т Murkamilov, V V Fomin
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Sovetskoe Zdravookhranenie Kirgizii|November 1, 1973
[Blood phospholipids in patients with Down's disease]K A Aitbaev
Klinicheskaia Meditsina|October 11, 2018
[INTESTINAL MICROBIOTA: ITS ROLE IN PATHOGENESIS OF ARTERIAL HYPERTENSION]K A Aitbaev, I E Murkamilov
Klinicheskaia Meditsina|October 6, 2018
[Peculiarities of progression of chronic glomerulonephritis associated with anemia]I T Murkamilov, K A Aitbaev, R Kaliev
Terapevticheskii Arkhiv|December 6, 2022
[Circulating microRNAs as potential biomarkers of chronic kidney disease]K A Aitbaev, I T Murkamilov, V V Fomin
Kardiologiia|March 12, 2019
K A Aitbaev, I T Murkamilov, V V Fomin
Terapevticheskii Arkhiv|December 30, 2023
[Prevalence, age and gender features of chronic kidney disease in patients with diabetes mellitus]I T Murkamilov, K A Aitbaev, V V Fomin
Terapevticheskii Arkhiv|July 27, 2017
[Gender features of cardiovascular events in patients with chronic glomerulonephritis at the pre-dialysis stage of the disease]I T Murkamilov, K A Aitbaev, V V Fomin
Terapevticheskii Arkhiv|September 16, 2017
[Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation]K A Aitbaev, I T Murkamilov, V V Fomin
Advances in Gerontology = Uspekhi Gerontologii|June 23, 2019
[Molecular mechanisms of aging: the role of oxidative stress and epigenetic modifications.]K A Aitbaev, I T Murkamilov, V V Fomin
Terapevticheskii Arkhiv|February 1, 2019
Inhibition of HIF-prolyl 4-hydroxylases as a promising approach to the therapy of cardiometabolic diseasesK A Aitbaev, I Т Murkamilov, V V Fomin
Pageof 4